DayTwo Company
DayTwo is the leader in precision nutrition for metabolic disease using gut microbiome science, AI and virtual clinical support.
Investors
.jpg)
%20.jpg)
Founded Date:
2015-08-01
Estimated Revenue:
Less than $1M
Total Funding:
90414821
Investors Number:
18
Employee Number:
51-100
Number Of Exists:
N/A
Last Funding Type:
Series B
Industry:
Anti-aging Therapies
Headquarters:
Walnut Creek, California, United States
Funding Status:
Early Stage Venture
Last Funding Date:
2021-05-31